William Groh to Anti-Arrhythmia Agents
This is a "connection" page, showing publications William Groh has written about Anti-Arrhythmia Agents.
Connection Strength
0.829
-
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2011 Jan 25; 76(4):409; author reply 409.
Score: 0.342
-
Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999 Oct; 10(10):1335-9.
Score: 0.156
-
Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation. J Cardiovasc Electrophysiol. 1997 May; 8(5):529-36.
Score: 0.132
-
Hypotonic-induced stretch counteracts the efficacy of the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Cardiovasc Res. 1996 Feb; 31(2):237-45.
Score: 0.121
-
Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1245-7.
Score: 0.052
-
The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes. Biochem Biophys Res Commun. 1994 Jul 15; 202(1):265-70.
Score: 0.027